Breakthrough Pulse
Oximetry
LIST PRICE $2800 OUR PRICE $1050 new in the box !!!
MARS Motion Artifact Rejection System
Exceptional Performance…
MARS Technology is the next generation in pulse oximetry
monitoring from Novametrix. As an addition to our current family
of “digital” pulse oximeters, MARSpO2™
takes advantage of new technological breakthroughs in signal
processing. This provides improved analysis of the pulse signal
resulting in superior performance during challenging clinical
conditions such as motion or low perfusion.
Half
the cost…
Novametrix offers this new technology as part of our unique Cost
Capitation Program which can
reduce pulse oximetry operating costs by 40-60% over
traditional “disposable sensor” programs. |
MARSpO2™
MOTION ARTIFACT REJECTION SYSTEM
The new Model 2001 Pulse Oximeter |
Data and Alarms when you Really Need Them!
Data and
Alarms when you Really Need Them!
There are two problems which have plagued traditional pulse oximeters;
the need to obtain readings under adverse conditions and the ability
to alarm only when appropriate.
Due to limited technology, it is difficult for
traditional pulse oximeters to read poor quality signals. Because of
this the pulse oximeter may blank its display and alarm or display
erratic values while it searches for a good quality signal. MARS
technology provides reliable readings more often even in the presence
of excessive motion or low perfusion.
During our product validation process, three
pulse oximeters were tested under simulated conditions of low and high
frequency motion and varying signal strength conditions. Table 1 shows
the MARS technology outperformed the other monitors under these
conditions.
 Breakthrough
Motion Artifact Rejection Technology at Half the Cost!
 Reduce
Pulse Oximetry Operating Costs by 40 to 60%
The Novametrix Pulse Oximetry
Cost Capitation Program is a comprehensive program designed to
partner with hospitals to achieve the following objectives:
-
Enhance pulse oximetry patient care outcomes through the use of
state-of-the-art oximetry technology.
-
Achieve 40-60% reductions in operating costs by replacing costly
disposable sensors with a high quality reusable sensor program.
-
Provide one low fixed operating cost over the life of the program.
| MARSpO2™
is a trademark (™) of Novametrix Medical Systems Inc. |
|
